Re:Multiple sclerosis has a common viral culprit, opening do...
by refurb on Sunday August 14, 2022 @10:00PM
(#32465062)
Rituximab was shown to be inferior in a head to head comparison against ocrelizumab.
[ Parent
| on HN ]
There are no comments on this comment yet.